John L. Magnani
Net worth: 634 278 $ as of 2024-04-29
Network origin in John L. Magnani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John L. Magnani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Sales & Marketing General Counsel Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Chairman | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| University of Maryland | College/University | Undergraduate Degree Masters Business Admin | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Founder | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| University of Maryland University College | College/University | Undergraduate Degree | |
| TESARO INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer | |
Carrick Therapeutics UK Ltd.
 Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Gw School of Medicine & Health Sciences | College/University | Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree | |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| XENCOR, INC. | Biotechnology | Director/Board Member | |
| Holy Cross Hospital (Maryland) | Corporate Officer/Principal | ||
| National Center for Health Statistics | General Government | Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree | |
| CIGNA Insurance Co. of North America (UK) Ltd. | Corporate Officer/Principal | ||
Deluxe Business Operations, Inc.
 Deluxe Business Operations, Inc. Commercial Printing/FormsCommercial Services Deluxe Business Operations, Inc. used to design and produce printed products. The company products are business forms, checks, envelopes, labels and greeting cards, retail merchandising aids, packaging, shipping and warehouse supplies. The company was founded in 1952 and was headquartered in Groton, MA. | Commercial Printing/Forms | Director of Finance/CFO | |
Integrated Health Services, Inc.
 Integrated Health Services, Inc. Hospital/Nursing ManagementHealth Services Integrated Health Services, Inc. provides post-acute healthcare services. Its Post-acute care is the provision of a continuum of care to patients following discharge from an acute care hospital. Its post-acute care services and products include inpatient services, home respiratory care & durable medical equipment, diagnostic services and lithotripsy which is a non-invasive technique that uses shockwaves to disintegrate kidney stones primarily on an outpatient basis. The company's post-acute care network is designed to address the cost containment measures implemented by private insurers & managed care organizations and limitations on government reimbursement of hospital costs that have resulted in the discharge from hospitals of many patients who continue to require medical and rehabilitative care. | Hospital/Nursing Management | Corporate Officer/Principal | |
| NEA 12 GP LLC | Corporate Officer/Principal | ||
| Bethesda Research Laboratories, Inc. | Chief Executive Officer | ||
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Founder |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Canada | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Health Services | 4 |
| Government | 3 |
Operational
| Director/Board Member | 117 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 36 |
| Undergraduate Degree | 31 |
| Chief Executive Officer | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Evan S. Melrose | 32 |
| Mark Goldberg | 17 |
| Scott Jackson | 15 |
| Timothy Pearson | 15 |
| Rachel King | 14 |
| Scott Koenig | 13 |
| Lisa V. DeLuca | 13 |
| Mike A. Henos | 11 |
| Patricia Andrews | 11 |
| Daniel Junius | 10 |
| John J. Baldwin | 10 |
| Bill M. Gust | 9 |
| Armand Girard | 8 |
| Brian Hahn | 8 |
- Stock Market
- Insiders
- John L. Magnani
- Company connections
